FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/095765 [Registered on: 09/10/2025] Trial Registered Prospectively
Last Modified On: 08/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study testing if adding a small dose of steroid medicine makes anaesthesia for children’s lower-body surgeries work better and last longer 
Scientific Title of Study   Efficacy of caudal block with or without Dexamethasone as an adjuvant by using perfusion index as an indicator in paediatric patients undergoing infra-umbilical surgeries- A Randomized double-blind, controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shreja Saha 
Designation  Post Graduate Trainee - 1(M.D Anaesthesiology) 
Affiliation  Kalinga Institute Of Medical Sciences 
Address  Department of Anaesthesiology, Kalinga Institute of Medical Sciences, Third Floor, Bhuwaneswar,Orissa Khordha

Khordha
ORISSA
751024
India 
Phone  8017128573  
Fax    
Email  shrejasaha@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Umesh Kumar Dash 
Designation  Professor(Anaesthesiology) 
Affiliation  Kalinga Institute Of Medical Sciences 
Address  Department of Anaesthesiology, Kalinga Institute of Medical Sciences, Third Floor, Bhuwaneswar,Orissa

Khordha
ORISSA
751024
India 
Phone  8779478574  
Fax    
Email  gasdoc2001@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sapna Das 
Designation  Assistant Professor 
Affiliation  Kalinga Institute Of Medical Sciences 
Address  Department of Anaesthesiology, Kalinga Institute of Medical Sciences, Third Floor, Bhuwaneswar,Orissa

Khordha
ORISSA
751024
India 
Phone  9078826164  
Fax    
Email  dr.sapnadas88@gmail.com  
 
Source of Monetary or Material Support  
Kalinga Institute of Medical Sciences, Third Floor, Bhuwaneswar, Orissa Khordha 751024 India  
 
Primary Sponsor  
Name  Dr Shreja Saha 
Address  Department of Anaesthesiology, Kalinga Institute of Medical Sciences, Third Floor, Bhuwaneswar,Orissa PIN-751024 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shreja Saha  Pradyumna Bal Memorial Hospital, Kalinga Institute of Medical Sciences  Department of Anaesthesiology, Kalinga Institute of Medical Sciences,Bhuwaneswar,Orissa Khordha, 751024
Khordha
ORISSA 
8017128573

shrejasaha@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE KALINGA INSTITUE OF MEDICAL SCIENCES  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  , (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1 ml/kg of 0.125% Bupivacaine with 0.1 mg/kg Dexamethasone  Group D: Patients will receive caudal block with local anaesthetic 0.125% bupivacaine 1ml/kg and dexamethasone (0.1 mg/kg to be prepared with volume of 2 ml) as adjuvant once the patient induced 
Comparator Agent  1 ml/kg of 0.125% Bupivacaine with saline  Group S: Patients will receive caudal block with local anaesthetic 0.125% bupivacaine 1ml/kg with 2ml of normal saline once the patient is induced.  
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  1. American Society of Anaesthesiologists (ASA) physical status I, II and III
2. Age- 2 -10 yrs patients
3. Posted for elective infra umbilical surgeries (e.g., inguinal hernia repair, orchidopexy, circumcision, lower limb procedures) requiring caudal block.
 
 
ExclusionCriteria 
Details  1. Suspected coagulopathy
2.Patients with severe peripheral vascular disease, Raynauds disease, or poor peripheral circulation.
3. Known allergy to drugs used in the study
4. Patients with infection at the site of caudal block, sacral bone abnormalities.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Change in perfusion index (PI) after caudal block   baseline value, intraoperatively in intervals of 15 minutes and postoperatively at intervals of 3 hours, 6 hours, 9 hours and 12-hour.
 
 
Secondary Outcome  
Outcome  TimePoints 
Assess change in intraoperative heart rate, Blood pressure and Spo2 after caudal block  Intraoperatively every 15 mins and postoperative hemodynamic changes and postoperatively at intervals of 3 hours, 6 hours, 9 hours and 12-hours. 
Post operative pain is observed using Face Pain Scale  At intervals of 3 hours, 6 hours, 9 hours and up to 12 hours 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   19/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Caudal block is used for pain relief in paediatric infraumbilical surgeries. Adding dexamethasone prolongs analgesia and improves perfusion. Perfusion Index, measured by pulse oximetry, serves as an early marker of block effectiveness. Children will undergo preanesthetic evaluation, consent, and premedication with IV midazolam. Standard monitoring will be applied, and anaesthesia induced with sevoflurane or propofol, along with fentanyl and muscle relaxant. After airway management, anaesthesia will be maintained with oxygen, Nitrous oxide, and sevoflurane. A caudal block will be performed: Group S will receive 0.125% Bupivacaine with saline, while Group D will receive 0.125% bupivacaine with 0.1mg/kg dexamethasone. Intraoperative monitoring of PI,HR, BP, oxygen saturation will be recorded every 15 minutes. Postoperatively, PI and hemodynamic parameters will be assessed at 3, 6, 9, and 12 hours, along with pain scores using the Faces Pain Scale. 
Close